EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viable cartilage allograft outperforms existing treatments for focal knee cartilage defects

Bhumit Desai, Eric Assid, Graylin Jacobs, Anouska Dasgupta, Gerard Williams, Walter Stephen Choate, Scott Montgomery, Brian Godshaw, Misty Suri, Deryk Jones

Knee Surgery, Sports Traumatology, Arthroscopy · 2024

DOI: 10.1002/ksa.12074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, 2024. Verfasst von Bhumit Desai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ochsner Medical Center, Department of Orthopaedic Surgery, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Cartilage, Articular, Cartilage Diseases, Osteoarthritis, Knee, Knee Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Viable cartilage allograft (VCA) is a cartilage tissue matrix that contains cryopreserved viable allogeneic cartilage fibres. This study aimed to assess safety and benefits in treating focal knee cartilage defects with VCA. We hypothesized that VCA is a safe single‐stage procedure in isolated chondral defects.

Method

In vitro analysis, in vivo studies and a prospective case series were performed. VCA was evaluated in a goat cartilage repair model. Symptomatic International Cartilage Repair Society grade 3/4A lesions of the femoral condyle or patella were implanted with VCA. International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome (KOOS) subscales, Lysholm, Short Form‐12, Visual Analog Scale and pain frequency levels were assessed. Radiographic and magnetic resonance imaging (MRI) was performed at regular intervals postoperatively. Data were analysed by statisticians to determine the power and significance of the results.

Results

The goat study confirmed that VCA is effective for cartilage repair. Twenty patients were implanted; the mean age was 28.1 (16–56), the mean body mass index (BMI) was 27.9 ± 5.6 and the mean follow‐up was 24.1 months (range = 12.0–36.0 months). Lesions were in either the femoral condyle (7) or patella (13). Lesion sizes ranged from 1.5 to 6.0 cm 2 (mean = 4.58 cm 2 ). Outcome scores improved from preoperative baseline (POB): IKDC (78.2), Lysholm (89.0), KOOS: Pain (95.8), Symptoms (86.3), ADL (87.8), Sports (85.0) and QOL (75.0). MRI imaging demonstrated excellent osteochondral allograft assimilation. Second‐look arthroscopy (two patients) demonstrated complete fill and incorporation (Brittberg scores 11/12). Functional scores were maintained at 24 (M): IKDC (86.24 ± 17.2), Lysholm (87.23 ± 15.0), KOOS: Pain (91.72 ± 17.3), Symptoms (84.92 ± 16.1), ADLs (93.80 ± 16.1), Sports (84.45 ± 27.7), QOL (81.30 ± 20.8).

Conclusion

VCA is an off‐the‐shelf, single‐stage, conformable allogeneic graft that treats chondral defects with no additional fixation. Preclinical and short‐term prospective clinical studies show that VCA can safely treat chondral defects with potential advantages to existing options. Level of Evidence Level IV study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage, ArticularCartilage DiseasesOsteoarthritis, KneeKnee InjuriesHumansAnimalsAdultQuality of LifeTreatment OutcomeKnee JointMagnetic Resonance ImagingAllograftsPainGoatsFollow-Up Studies

Stichwörter der Autor:innen

allograftarticularbiologycartilagekneeregeneration

Autor:innen und Institutionen

  • Ochsner Medical Center, Department of Orthopaedic Surgery, New Orleans, Louisiana, USA.
  • Ochsner Sports Medicine Institute, University of Queensland, Ochsner Clinical School, New Orleans, Louisiana, USA.
  • MTF (Musculoskeletal Transplant Foundation) Biologics, Edison, New Jersey, USA.
  • Howard University Orthopaedic Hospital, Washington, District of Columbia, USA.

Förderung

  • None

Zitieren

APA

Desai, B., Assid, E., Jacobs, G., Dasgupta, A., Williams, G., Choate, W. S., Montgomery, S., Godshaw, B., Suri, M., & Jones, D. (2024). Viable cartilage allograft outperforms existing treatments for focal knee cartilage defects. Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1002/ksa.12074

Vancouver

Desai B, Assid E, Jacobs G, Dasgupta A, Williams G, Choate WS, et al. Viable cartilage allograft outperforms existing treatments for focal knee cartilage defects. Knee Surgery, Sports Traumatology, Arthroscopy. 2024. doi:10.1002/ksa.12074

BibTeX
@article{Desai2024,
  author = {Desai, Bhumit and Assid, Eric and Jacobs, Graylin and Dasgupta, Anouska and Williams, Gerard and Choate, Walter Stephen and Montgomery, Scott and Godshaw, Brian and Suri, Misty and Jones, Deryk},
  title = {Viable cartilage allograft outperforms existing treatments for focal knee cartilage defects},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2024},
  doi = {10.1002/ksa.12074}
}
Kostenlos starten →